765916-82-3 Usage
Uses
Used in Organic Synthesis:
3,5-DIFLUORO-4-(TRIBUTYLSTANNYL)PYRIDINE is used as a reagent for introducing the tributylstannyl group into various organic molecules. The tributylstannyl group acts as a handle for further functionalization or as a protecting group for sensitive functional groups in organic synthesis.
Used in the Development of New Materials:
The presence of the fluorine atoms in 3,5-DIFLUORO-4-(TRIBUTYLSTANNYL)PYRIDINE imparts unique chemical properties to the compound, making it valuable in the development of new materials with specific characteristics.
Used in Pharmaceutical Development:
Due to its unique structure and properties, 3,5-DIFLUORO-4-(TRIBUTYLSTANNYL)PYRIDINE is also utilized in the pharmaceutical industry for the development of new drugs, where the tributylstannyl group and fluorine atoms can contribute to the compound's bioactivity and pharmacokinetic properties.
Check Digit Verification of cas no
The CAS Registry Mumber 765916-82-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,5,9,1 and 6 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 765916-82:
(8*7)+(7*6)+(6*5)+(5*9)+(4*1)+(3*6)+(2*8)+(1*2)=213
213 % 10 = 3
So 765916-82-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H2F2N.3C4H9.Sn/c6-4-1-5(7)3-8-2-4;3*1-3-4-2;/h2-3H;3*1,3-4H2,2H3;/rC17H29F2NSn/c1-4-7-10-21(11-8-5-2,12-9-6-3)17-15(18)13-20-14-16(17)19/h13-14H,4-12H2,1-3H3
765916-82-3Relevant academic research and scientific papers
Beta-carbolines useful for treating inflammatory disease
-
Page/Page column 85; 106, (2010/02/14)
This invention provides beta-carboline compounds of formula III-A-aa: wherein Q, G, R1, R2, R3, and R6b are as described in the specification. The compounds are useful for treating diseases such as inflammatory diseases and cancer.
BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE
-
Page 138, (2010/02/09)
This invention provides beta-carboline compounds of formula (I) wherein Ring A is a substituted pyridinyl, pyrimidinyl, morpholinyl, piperidinyl, piperazinyl, pyrrolidinyl, pyranyl, tetrahydrofuranyl, cyclohexyl, cyclopentyl or thiomorpholinyl ring and R1, R2 and R3 are as described in the specification. The compounds are IKK-2 inhibitors that are useful for treating IKK-2 mediated diseases such as inflammatory diseases and cancer.
